We recognize PPS IB encompasses a wide range of AS; yet we purposely included patients with LA-HR+/HER2- breast cancer in this study because the most striking difference is present between AS (IIIA/B) and PPS (IB) for these patients. This evidence concerns the gene HR and breast cancer.